Vivos Therapeutics is a medical technology company focused on the development and commercialization of a suite of diagnostic and treatment modalities for patients with cranial and/or dentofacial abnormalities and the array of medical conditions that may result from them, including mild to moderate obstructive sleep apnea and snoring in adults. Co. calls its solution The Vivos Method. The Vivos Method is a therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by Co. and prescribed by trained dentists in cooperation with their medical colleagues. The VVOS stock yearly return is shown above.
The yearly return on the VVOS stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2023 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the VVOS annual return calculation with any dividends reinvested as applicable (on ex-dates).
|